Qianxiong Zhou
Overview
Explore the profile of Qianxiong Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng J, Wang X, Du H, Zhang R, Huo X, Zhou T, et al.
J Inorg Biochem
. 2024 Nov;
262:112771.
PMID: 39504917
Among the many cancer treatment methods, there have been many reports on the use of nanoplatforms with single treatment methods such as photothermal, photodynamic or chemodynamic for cancer treatment. In...
2.
Zhu H, Cui M, Tang Q, Zhao H, Zhang P, Zeng S, et al.
Biomater Sci
. 2024 Apr;
12(12):3154-3162.
PMID: 38687170
The effectiveness of photodynamic therapy (PDT) has been greatly restricted by the hypoxic tumor microenvironment and the susceptible resistance of monotherapy. Although nanodrugs based on transition metal complexes capable of...
3.
Peng Y, Da X, Zhou W, Xu Y, Liu X, Wang X, et al.
Dalton Trans
. 2024 Feb;
53(8):3579-3588.
PMID: 38314620
Photodynamic therapy (PDT) is promising for cancer treatment but still suffers from some limitations. For instance, PDT based on O generation (in a type-II mechanism) is heavily dependent on high...
4.
Zhou W, Da X, Jian Y, Peng Y, Liu X, Xu Y, et al.
Chemistry
. 2024 Jan;
30(16):e202303766.
PMID: 38233363
Intracellular Staphylococcus aureus (S. aureus), especially the methicillin resistant staphylococcus aureus (MRSA), are difficult to detect and eradicate due to the protection by the host cells. Antibacterial photodynamic therapy (aPDT)...
5.
Zhu L, Liu H, Dou Y, Luo Q, Gu L, Liu X, et al.
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175463
The ruthenium polypyridine complex [Ru(dppa)(pytp)] (PF) (termed as ZQX-1), where dppa = 4,7-diphenyl-1,10-phenanthroline and pytp = 4'-pyrene-2,2':6',2''-terpyridine, has been shown a high and selective cytotoxicity to hypoxic and cisplatin-resistant cancer...
6.
Jian Y, Peng Y, Zhou W, Xu Y, Li C, Wang X, et al.
ChemMedChem
. 2023 Feb;
18(9):e202300065.
PMID: 36751034
Drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), pose a serious threat to human life. Therefore, there is urgent need to develop antibiotics with new chemical structures and antibacterial mechanisms,...
7.
Sun W, Boerhan R, Tian N, Feng Y, Lu J, Wang X, et al.
RSC Adv
. 2022 May;
10(42):25364-25369.
PMID: 35517482
Fluorination in enhancing photoactivated antibacterial activity of Ru(ii) complexes with photo-labile ligands was studied. Ru(ii) polypyridine complexes containing a di-fluorinated dppz (dipyrido[3,2-:2',3'-]phenazine) or mono-trifluoromethylated dppz bidentate ligand and four pyridine...
8.
Guo X, Li C, Wang W, Zhang B, Hou Y, Wang X, et al.
RSC Adv
. 2022 Apr;
11(39):24359-24365.
PMID: 35479006
Three new isomeric cobalt complexes of TPA (tris(2-pyridylmethyl)amine) based on methoxy substitution at the , and positions, respectively, were constructed and their photocatalytic proton reduction efficiencies were compared. It was...
9.
Wang Z, Gao C, Da X, Jian Y, Zhang C, Yao Y, et al.
Dalton Trans
. 2022 Feb;
51(8):3225-3233.
PMID: 35119445
Chemodynamic therapy (CDT) is novel and promising for cancer treatment, however, the potential systematic toxicity of the used nanoparticles is still a big concern. In this work the biocompatible hypocrellin...
10.
Guo L, Mohanty J, Liu W, Yonar T, Sun H, Minami T, et al.
Front Chem
. 2021 Dec;
9:811459.
PMID: 34900950
No abstract available.